Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Beswick

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|October 7, 2022
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of CancerGemma E Mudd, Heather Scott, Liuhong Chen, et al.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
ACS Nano|February 13, 2026
Utilizing Constrained Bicyclic Peptides for <i>In Vitro</i> DiagnosticsAndré Shamsabadi, Adam Creamer, Christy J Sadler, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Journal of Medicinal Chemistry|October 6, 2025
High-Throughput Identification and Characterization of LptDE-Binding Bicycle Peptides Using Phage Display and Cryo-EMShenaz Allyjaun, Emily Dunbar, Steven W Hardwick, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
Nature Communications|June 16, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2Katherine U Gaynor, Marina Vaysburd, Maximilian A J Harman, et al.
Nucleic Acids Research|April 10, 2025
Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac musclesMichael E Østergaard, Michele Carrer, Brooke A Anderson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|October 7, 2022
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of CancerGemma E Mudd, Heather Scott, Liuhong Chen, et al.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
ACS Nano|February 13, 2026
Utilizing Constrained Bicyclic Peptides for <i>In Vitro</i> DiagnosticsAndré Shamsabadi, Adam Creamer, Christy J Sadler, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Journal of Medicinal Chemistry|October 6, 2025
High-Throughput Identification and Characterization of LptDE-Binding Bicycle Peptides Using Phage Display and Cryo-EMShenaz Allyjaun, Emily Dunbar, Steven W Hardwick, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
Nature Communications|June 16, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2Katherine U Gaynor, Marina Vaysburd, Maximilian A J Harman, et al.
Nucleic Acids Research|April 10, 2025
Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac musclesMichael E Østergaard, Michele Carrer, Brooke A Anderson, et al.
Pageof 2